drugset / Trial / NCT01041274

DECIFER: Depression and Citalopram In First Episode Recovery

NCT01041274

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study seeks to examine the effectiveness of citalopram added to treatment with any oral or injectable second-generation antipsychotic plus standardized psychoeducation in first episode schizophrenia patients. Because depressive symptoms are common in first episode patients, we will test the hypothesis that adding the SSRI citalopram to a pre-established medication regimen will improve quality of life and decrease relapse and suicidality over the course of a 12-month trial.

Timeline

Start
2010-01
Primary completion
2014-12
Completion
2018-03-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule 40 mg Oral